Skip to content

Audion ET Dilation System

by Entellus Medical, Inc 510(k)

Active United States

510(k) K220027

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK220027 Date12 Apr 2022ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
PNZ
FDA applicant
Entellus Medical, Inc.
Device Class
Class II
Regulation
21 CFR Part 874.4180
Advisory Committee
Ear, Nose, Throat
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Audion ET Dilation System is a Eustachian Tube Balloon Dilation Device, classified under regulation 21 CFR 874.4180. This device is designed for the dilation of the Eustachian tube, aiding in the relief of Eustachian tube dysfunction by mechanically widening the tube to restore proper ventilation and pressure equalization in the middle ear.

The system is supplied as a single-use, sterile medical device and is intended for use in clinical settings by qualified healthcare professionals. It is regulated as a Class II device under FDA 510(k) clearance (K220027) via the Traditional pathway, with a product code of PNZ. No additional regulatory markings or MRI safety classifications are specified in the available data.

Other devices from Entellus Medical, Inc

See all devices from Entellus Medical, Inc →

Questions

AI-generated answers, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Audion ET dilation system designed to treat, and who should use it?

    The Audion ET dilation system is specifically designed to mechanically widen the Eustachian tube, helping to relieve Eustachian tube dysfunction. This condition can cause issues like pressure imbalances or ventilation problems in the middle ear, often leading to symptoms like ear fullness or popping. It is intended for use by qualified healthcare professionals in clinical settings, such as ENT (ear, nose, and throat) specialists, to perform the dilation procedure.

  • Is the Audion ET dilation system reusable or single-use, and how should it be stored?

    The Audion ET dilation system is supplied as a single-use, sterile medical device, meaning it is intended for one-time use only and should not be reused. Since it is sterile, it should be stored in its original packaging until ready for use, following the manufacturer’s instructions to maintain sterility and integrity. Proper storage conditions, such as avoiding extreme temperatures or moisture, are critical to preserving its functionality.

  • What regulatory pathway was used for FDA clearance of the Audion ET dilation system, and what does that mean for its use?

    The Audion ET dilation system received FDA clearance through the Traditional 510(k) pathway, which means it was determined to be substantially equivalent to a legally marketed predicate device. This clearance confirms that the device meets FDA standards for safety and effectiveness as intended for its use in mechanically dilating the Eustachian tube. The product code PNZ and classification under 21 CFR 874.4180 further indicate its regulatory classification as a Class II device.

  • Are there different sizes or models of the Audion ET dilation system, and if so, how do they differ?

    The data provided lists multiple registration numbers associated with the Audion ET dilation system, which may correspond to different lot or batch identifiers rather than distinct sizes or models. However, the system itself is described as a single device type for Eustachian tube dilation. If specific sizes or variations exist, they would likely be detailed in the manufacturer’s instructions or product documentation, but no explicit differences are mentioned in the available regulatory data.